{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:01:02Z","timestamp":1778115662142,"version":"3.51.4"},"reference-count":31,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0973-1482.199447","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T04:13:58Z","timestamp":1498104838000},"page":"291","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of clinical process in osteosarcoma patients treated with chemotherapy including cisplatin, adriamycin, ifosfamide, and etoposide and determination of the treatment sequels in a long-term 11-year follow-up"],"prefix":"10.4103","volume":"13","author":[{"given":"Mozaffar","family":"Aznab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hematti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0973-1482.199447-1","first-page":"1208","volume-title":"The World Health Organization's histologic classification of bone tumors.A commentary on the second edition","author":"Schajowicz","year":"1995","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-2","unstructured":"Ghadirian P, Fathie K, Emard JF. Epidemiology of Bone Cancer: An Overview. 40th Annual Scientific Meeting. Somerset Inn, Troy, MI; 17-18 June, 2016."},{"key":"key-10.4103\/0973-1482.199447-3","first-page":"2398","volume-title":"The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer","author":"Ries","year":"2000","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-4","first-page":"1531","volume-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-5","first-page":"3","volume-title":"The epidemiology of osteosarcoma","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat Res"},{"key":"key-10.4103\/0973-1482.199447-6","first-page":"S90","volume-title":"Low-grade osteogenic sarcoma arising in medullary and surface osseous locations.Am J Clin Pathol","author":"Antonescu","year":"2000","journal-title":""},{"key":"key-10.4103\/0973-1482.199447-7","first-page":"152","volume-title":"Pediatric surface osteosarcoma: Clinical, pathologic, and radiologic features","author":"Kaste","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.4103\/0973-1482.199447-8","first-page":"776","volume-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","author":"Bielack","year":"2002","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-9","first-page":"1574","volume-title":"Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651","author":"Goorin","year":"2003","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-10","first-page":"1600","volume-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","author":"Link","year":"1986","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.199447-11","first-page":"5888","volume-title":"Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma","author":"Bernthal","year":"2012","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-12","first-page":"2497","volume-title":"Declining childhood and adolescent cancer mortality","author":"Smith","year":"2014","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-13","first-page":"137","volume-title":"Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","author":"Bielack","year":"2009","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.199447-14","first-page":"670","volume-title":"Sequelae of osteosarcoma medical therapy: A review of rare acute toxicities and late effects","author":"Janeway","year":"2010","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1482.199447-15","first-page":"339","volume-title":"Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: Treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide","author":"Bacci","year":"2000","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0973-1482.199447-16","first-page":"1579","volume-title":"A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup","author":"Bramwell","year":"1992","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-17","first-page":"248","volume-title":", Higby DJ, Mindell ER, Nime F, Ghoorah J, et al. Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma","author":"Ettinger","year":"1981","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-18","first-page":"2770","volume-title":"Frontline treatment of localized osteosarcoma without methotrexate: Results of the St.Jude Children's Research Hospital OS99 trial","author":"Daw","year":"2011","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-19","first-page":"A1201","volume-title":"Role of high dose ifosfamide in recurrent osteosarcoma","author":"Chawla","year":"1990","journal-title":"Proc Am Soc Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-20","first-page":"2112","volume-title":"Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian sarcoma group trial ISG\/OS-1","author":"Ferrari","year":"2012","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-21","first-page":"426","volume-title":"Phase II\/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial","author":"Goorin","year":"2002","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-22","first-page":"S25","volume-title":"A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people","author":"Magrath","year":"1986","journal-title":"Cancer Chemother Pharmacol"},{"key":"key-10.4103\/0973-1482.199447-23","doi-asserted-by":"crossref","unstructured":"Miser JS, Pritchard DJ, Rock MG, Shives Tc, Gilchrist GS, Smithson WA, et al. The Mayo Clinic studies. In: Humphrey GB, Koops HS, Molenaar WM, editors. Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Boston: Kluwer Academic Publishers; 1993.","DOI":"10.1007\/978-1-4615-3518-8_40"},{"key":"key-10.4103\/0973-1482.199447-24","first-page":"425","volume-title":"Link MP for Pediatric Oncology Group, Chicago, IL, USA.A phase I trial of etoposide (VP) and escalating doses of ifosfamide (IFOS) plus GCSF in recurrent pediatric sarcomas","author":"Goorin","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-25","first-page":"87","volume-title":"Treatment of osteosarcoma with ifosfamide: Comparison of response in pediatric patients with recurrent disease versus patients previously untreated: A Pediatric Oncology Group study","author":"Harris","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"key-10.4103\/0973-1482.199447-26","first-page":"1755","volume-title":", Krivit W, Bleyer WA, Hammond D.Phase II study of VP-16-213 in childhood malignant disease: A Children's Cancer Study Group Report","author":"Chard","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"key-10.4103\/0973-1482.199447-27","first-page":"3227","volume-title":"Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities.Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin","author":"Bacci","year":"1993","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.199447-28","first-page":"1191","volume-title":"Ifosfamide with mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults","author":"Miser","year":"1987","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.199447-29","first-page":"157","volume-title":"Time dependency of prognostic factors in patients with stage II osteosarcomas","author":"Kim","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"key-10.4103\/0973-1482.199447-30","first-page":"239","volume-title":"Osteosarcoma: Review of the past, impact on the future.The American experience","author":"Jaffe","year":"2009","journal-title":"Cancer Treat Res"},{"key":"key-10.4103\/0973-1482.199447-31","first-page":"332","volume-title":"Osteosarcoma of the pelvis","author":"Donati","year":"2004","journal-title":"Eur J Surg Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T10:19:04Z","timestamp":1569493144000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cancerjournal.net\/text.asp?2017\/13\/2\/291\/199447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"alternative-id":["199447"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.199447","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}